Gender Representation Among Academic US Radiation Oncology Department Chairs: Who are They?

Autor:	Hsieh K; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York., Bloom JR; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York., Jones BM; Department of Radiation Medicine, Northwell Health Cancer Institute, Lake Success, New York.; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York., Hsieh C; Department of Diagnostic Imaging, Warren Alpert Medical School of Brown University, Providence, Rhode Island., Hassan A; Department of Radiation Medicine, Northwell Health Cancer Institute, Lake Success, New York.; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York., Nehlsen AD; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York., Salgado LR; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York., Goodman KA; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York., Green S; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York., Rowley JP; Department of Radiation Oncology, Maimonides Cancer Center, Brooklyn, New York., Sindhu KK; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York.
Jazyk:	angličtina
Zdroj:	Advances in radiation oncology [Adv Radiat Oncol] 2024 Feb 01; Vol. 9 (5), pp. 101451. Date of Electronic Publication: 2024 Feb 01 (Print Publication: 2024).
DOI:	10.1016/j.adro.2024.101451
Abstrakt:	Purpose: Women are underrepresented in academic radiation oncology (RO), particularly in leadership positions. In this study, we sought to better understand the characteristics of individuals who currently serve as academic RO chairpersons at institutions with an associated Accreditation Council for Graduate Medical Education-accredited RO residency training program. Methods and Materials: We created a database of academic RO chairpersons in the United States by using publicly available sources, including residency training program websites, hospital/institutional websites, Doximity, LinkedIn, the American Society for Radiation Oncology (ASTRO) website, the American College of Radiation Oncology website, and the National Plan and Provider Enumeration System National Provider Identifier Registry. We used the χ 2 Goodness of Fit test, Mann-Whitney U test, and Fisher exact test via R version 4.1.1 to evaluate for statistical significance among categorical variables, medians, and proportions, respectively. Results: We identified 85 of the 90 chairpersons (94.4%) currently serving at institutions with an Accreditation Council for Graduate Medical Education-accredited RO residency training program, 5 of whom hold interim positions and were thus excluded from further analyses. Of the remaining 80 chairpersons, 9 (11.3%) are women, and 71 (88.8%) are men ( P < .01). Seventy-six chairpersons (95.0%) are full professors, and 19 (23.8%) hold dual MD PhD degrees. Thirty-two chairpersons (40.0%) hold an official leadership role in a cancer center affiliated with their current institution (43.7% of men vs 11.1% of women; P = .08). Seventy-three chairpersons (91.3%) secured their current positions a median of 16 years (range, 6-33 years) after completing RO residency. Thirty-five chairpersons (43.8%) were promoted to chair from positions within their current institutions (40.8% of men vs 66.7% of women; P = .17). The majority of chairpersons are ASTRO Fellows (62.5%); notably fewer are ASTRO (5.0%) or American College of Radiation Oncology (2.5%) Gold Medalists. Eight RO residency programs trained more than half of current chairpersons. Conclusion: Significantly more men than women currently serve as RO chairpersons. Future interventions that promote the recruitment, retention, and promotion of talented women in academic RO should be considered. Competing Interests: Kristin Hsieh is the 2023 American Society for Radiation Oncology AstraZeneca Radiation Oncology Research Training Fellow. Karyn A. Goodman participates in Viewray Data Safety Monitoring Board, RenovoRx Advisory Board, and Philips Advisory Board; and she is a cochair of National Cancer Institute Gastrointestinal Steering Committee. The remaining authors declare that they have no conflict of interest. (© 2024 The Author(s).)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu